GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » EV-to-EBITDA

Shanghai Hile Bio-Technology Co (SHSE:603718) EV-to-EBITDA : 114.79 (As of May. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shanghai Hile Bio-Technology Co's enterprise value is ¥4,659.5 Mil. Shanghai Hile Bio-Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥40.6 Mil. Therefore, Shanghai Hile Bio-Technology Co's EV-to-EBITDA for today is 114.79.

The historical rank and industry rank for Shanghai Hile Bio-Technology Co's EV-to-EBITDA or its related term are showing as below:

SHSE:603718' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2641.19   Med: 89.18   Max: 11669.87
Current: 114.46

During the past 13 years, the highest EV-to-EBITDA of Shanghai Hile Bio-Technology Co was 11669.87. The lowest was -2641.19. And the median was 89.18.

SHSE:603718's EV-to-EBITDA is ranked worse than
94.01% of 451 companies
in the Biotechnology industry
Industry Median: 9.51 vs SHSE:603718: 114.46

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), Shanghai Hile Bio-Technology Co's stock price is ¥7.36. Shanghai Hile Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.068. Therefore, Shanghai Hile Bio-Technology Co's PE Ratio for today is 108.24.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shanghai Hile Bio-Technology Co EV-to-EBITDA Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co EV-to-EBITDA Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.70 142.76 73.27 31.46 66.27

Shanghai Hile Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.48 27.90 39.04 66.27 143.55

Competitive Comparison of Shanghai Hile Bio-Technology Co's EV-to-EBITDA

For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Hile Bio-Technology Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shanghai Hile Bio-Technology Co's EV-to-EBITDA falls into.



Shanghai Hile Bio-Technology Co EV-to-EBITDA Calculation

Shanghai Hile Bio-Technology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4659.522/40.593
=114.79

Shanghai Hile Bio-Technology Co's current Enterprise Value is ¥4,659.5 Mil.
Shanghai Hile Bio-Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥40.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Hile Bio-Technology Co  (SHSE:603718) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shanghai Hile Bio-Technology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.36/0.068
=108.24

Shanghai Hile Bio-Technology Co's share price for today is ¥7.36.
Shanghai Hile Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.068.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shanghai Hile Bio-Technology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Hile Bio-Technology Co (SHSE:603718) Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
Executives
Zhang Lu Director
Liu Han Ping Directors, senior managers
Zhou Yu Sheng Supervisors
Zhang Hai Ming Director
Sun Guo Bao Supervisors
Zhang Yue Director
Su Bin Director
Wu Ling Yue senior management

Shanghai Hile Bio-Technology Co (SHSE:603718) Headlines

No Headlines